Evidence map›Paper›PMID 28373875›Full record

ArticleFrontiers in immunology2017

Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche.

Antonella Chillemi, Valeria Quarona, Luca Antonioli, Davide Ferrari, Alberto L Horenstein, Fabio Malavasi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Antonella ChillemiLaboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy.
Valeria QuaronaLaboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy.
Luca AntonioliDepartment of Clinical and Experimental Medicine, University of Pisa , Pisa , Italy.
Davide FerrariDepartment of Life Science and Biotechnology, University of Ferrara , Ferrara , Italy.
Alberto L HorensteinLaboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy.
Fabio MalavasiLaboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy.
University of Turin · ITUniversity of Ferrara · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ectoenzymes are cell surface molecules, which represent functional bridges between the environment and the cytoplasm. One set of ectoenzymes-CD39, CD38, CD203a, and CD73-leads to the generation of adenosine (ADO) by metabolizing ATP and NAD

Indexed as

adenosineCD38ectoenzymesmicrovesiclesmultiple myeloma therapy

Identifiers

PMID28373875
PMCPMC5357780
OpenAlexW2603125673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.